Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/20/13 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
   |
110 |
| 05/15/13 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
36 |
| 05/14/13 | 8-K | Current report filing |
|
12 | |
| 04/23/13 | UPLOAD | SEC-generated letter |
|
2 | |
| 04/18/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 04/18/13 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
|
109 |
| 04/15/13 | 8-K | Current report filing |
|
3 | |
| 04/05/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/03/13 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
68 |
| 04/02/13 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
3 |
